abstract |
The invention concerns an intravaginal device comprising a combination of 17 β-estradiol and a supporting matrix for treating hypoestrogenic women. The device releases continuously 17 β-estradiol at a rate of about 0.5 to about 25 μg/24 h. n The invention also comprises a method of preparing the device and a method of treating hypoestrogenic women by using the device. |